Latest Insider Transactions at Axonics, Inc. (AXNX)
This section provides a real-time view of insider transactions for Axonics, Inc. (AXNX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Axonics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Axonics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
3,979
-2.89%
|
$238,740
$60.73 P/Share
|
|
Feb 01
2023
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
931
-1.08%
|
$55,860
$60.73 P/Share
|
|
Feb 01
2023
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,117
-2.42%
|
$487,020
$60.73 P/Share
|
|
Feb 01
2023
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
3,246
-6.05%
|
$194,760
$60.73 P/Share
|
|
Feb 01
2023
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,705
-3.43%
|
$222,300
$60.73 P/Share
|
|
Feb 01
2023
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,075
-3.16%
|
$304,500
$60.73 P/Share
|
|
Jan 31
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
7,570
-5.05%
|
$461,770
$61.14 P/Share
|
|
Jan 31
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,125
+22.35%
|
-
|
|
Jan 31
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+13.78%
|
-
|
|
Jan 31
2023
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,703
-4.03%
|
$225,883
$61.14 P/Share
|
|
Jan 31
2023
|
Karen Noblett Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,250
+17.95%
|
-
|
|
Jan 31
2023
|
Karen Noblett Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+12.02%
|
-
|
|
Jan 31
2023
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,904
-6.16%
|
$1,397,144
$61.14 P/Share
|
|
Jan 31
2023
|
Raymond W Cohen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,968
+24.44%
|
-
|
|
Jan 31
2023
|
Raymond W Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,750
+13.8%
|
-
|
|
Jan 31
2023
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
10,511
-14.86%
|
$641,171
$61.14 P/Share
|
|
Jan 31
2023
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,250
+40.08%
|
-
|
|
Jan 31
2023
|
Danny L. Dearen President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+28.57%
|
-
|
|
Jan 31
2023
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,234
-5.25%
|
$380,274
$61.14 P/Share
|
|
Jan 31
2023
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+21.35%
|
-
|
|
Jan 31
2023
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+14.49%
|
-
|
|
Jan 31
2023
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
13,425
-7.39%
|
$818,925
$61.14 P/Share
|
|
Jan 31
2023
|
Rinda Sama Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,875
+24.67%
|
-
|
|
Jan 31
2023
|
Rinda Sama Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+12.13%
|
-
|
|
Jan 17
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
30,215
-12.98%
|
$2,024,405
$67.44 P/Share
|
|
Jan 17
2023
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,215
+10.79%
|
$302,150
$10.69 P/Share
|
|
Jan 13
2023
|
Alfred J Ford Jr Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36,015
-19.9%
|
$2,376,990
$66.59 P/Share
|
|
Jan 13
2023
|
Alfred J Ford Jr Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,015
+13.03%
|
$360,150
$10.77 P/Share
|
|
Jan 13
2023
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,736
-14.66%
|
$2,647,840
$65.9 P/Share
|
|
Dec 13
2022
|
Esteban Lopez |
SELL
Open market or private sale
|
Direct |
2,000
-35.71%
|
$134,000
$67.42 P/Share
|
|
Sep 13
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
656
-8.04%
|
$49,200
$75.6 P/Share
|
|
Sep 12
2022
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
32,483
-50.69%
|
$2,533,674
$78.16 P/Share
|
|
Sep 12
2022
|
Karen Noblett Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,483
+22.44%
|
$649,660
$20.01 P/Share
|
|
Sep 08
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
7,500
-7.54%
|
$562,500
$75.01 P/Share
|
|
Sep 08
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.01%
|
$7,500
$1.53 P/Share
|
|
Sep 07
2022
|
Karen Noblett Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,454
-24.86%
|
$742,234
$71.53 P/Share
|
|
Aug 25
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
7,500
-7.09%
|
$547,500
$73.13 P/Share
|
|
Aug 18
2022
|
Esteban Lopez |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+27.27%
|
-
|
|
Aug 18
2022
|
David M Demski |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+24.3%
|
-
|
|
Aug 18
2022
|
Jane E Kiernan |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+11.08%
|
-
|
|
Aug 18
2022
|
Nancy Lynn Md Snyderman |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+11.03%
|
-
|
|
Aug 18
2022
|
Robert Mc Namara |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+15.04%
|
-
|
|
Aug 18
2022
|
Michael H Carrel |
BUY
Grant, award, or other acquisition
|
Direct |
2,100
+12.03%
|
-
|
|
Aug 11
2022
|
Danny L. Dearen President & CFO |
SELL
Open market or private sale
|
Direct |
50,000
-47.97%
|
$3,550,000
$71.26 P/Share
|
|
Aug 11
2022
|
Danny L. Dearen President & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,502
+13.52%
|
$300,016
$8.86 P/Share
|
|
Aug 10
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
SELL
Open market or private sale
|
Direct |
15,000
-11.61%
|
$1,035,000
$69.78 P/Share
|
|
Aug 10
2022
|
John Woock EVP, Chief Mktg/Strtgy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+9.87%
|
$7,500
$1.63 P/Share
|
|
Aug 10
2022
|
Rinda Sama Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
33,850
-21.15%
|
$2,335,650
$69.74 P/Share
|
|
Aug 10
2022
|
Rinda Sama Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,850
+12.55%
|
$609,300
$18.07 P/Share
|
|
Aug 08
2022
|
Raymond W Cohen Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
44,000
-6.19%
|
$3,080,000
$70.91 P/Share
|